17, Jul 2024
Jambo Expands to Solana with Tether to Bring Blockchain Mobile Technology to Emerging Markets
Lagos, July 17, 2024 – Today, Jambo, the largest web3 mobile infrastructure bringing emerging markets on-chain, announced that it’s expanding to the Solana blockchain along with Tether to offer blockchain-enabled financial and educational technologies that cater to emerging markets.
Central to this is the JamboPhone, a $99 web3 smartphone that has been powerful in onboarding all types of users on-chain in a mobile-first way. Combined with the Solana blockchain’s high throughput capabilities and Tether’s dominant stablecoin, USDT, access to web3 financial and educational products will be democratized to those who need them most in Southeast Asia, Africa, and Latin America.
Jambo is officially expanding to @solana with @Tether_to to bring blockchain mobile tech & solutions to emerging markets! https://t.co/EEkYPUiKdl
— Jambo (@JamboTechnology) July 16, 2024
Introducing the JamboPhone
Available in over 120 countries, the JamboPhone is targeted towards Gen Z consumers in emerging markets as their portal to the best digital products and opportunities globally. Users can engage with the global economy by utilizing the preloaded Jambo Ecosystem applications featuring DeFi, gaming, and web3 infrastructure applications. The JamboPhone aims to address some of the most challenging issues faced by emerging markets, such as a large unbanked population and limited access to smartphones. Users can purchase the JamboPhone with Solana Pay on JamboPhone.xyz.
The Jambo App: Empowering Users
The smartphone is equipped with the JamboApp, a comprehensive web3 platform that offers users a range of services including decentralized finance, gaming, and educational content, all designed with the emerging market user in mind. The JamboApp includes the JamboWallet, a non-custodial multichain wallet which includes support for Solana tokens and USDT. Jambo will be giving out rewards primarily in USDT, leveraging its broad acceptance and stability in emerging markets. Users will be able to complete quests sponsored by Jambo and Jambo ecosystem partners, ranging from educational initiatives to promotional tasks, with rewards now distributed primarily using SPL USDT. This initiative underscores Jambo, Solana, and Tether’s role as pioneers in bridging the digital divide, aiming to democratize access to digital financial tools and providing users with earning opportunities in emerging markets.
Leveraging Local Solana Communities
Additionally, Jambo will engage local Superteams to accelerate web3 adoption. Superteam is a global community of web3 builders who are passionate about Solana. Their mission is to help web3 talent learn, earn, and connect with the Solana ecosystem. These teams, composed of local experts and enthusiasts, will play a pivotal role in educating communities, fostering local development, and driving grassroots initiatives that ensure sustainable growth within the web3 ecosystem.
“Back when I was building earn.com in 2017, our vision was to build a product ‘where there’s a phone, there’s a job.’ Alice, James, and the Jambo team have realized that vision by developing web3 mobile infrastructure bringing financial access to emerging markets,” said Lily Liu, President of the Solana Foundation. “Jambo offers a gateway to web3 that is accessible to nearly anyone in the world, while Solana enables financial access for nearly anyone with an internet connection. Together, we are committed to making self-custody, financial opportunity, and educational resources accessible to millions.”
Why Emerging Markets
Emerging markets face their own unique set of economic challenges that Solana and Tether can address with their blockchain and stablecoin solutions. In emerging markets, the use of USDT (Tether) significantly surpasses that of other stablecoins, with over 34.2 million unique wallets utilizing USDT as of April 2024. This broad user base highlights the widespread trust and adoption of Tether in these regions. With Jambo’s game-changing smartphone, Solana’s fast transaction processing, low transaction fees, and Tether’s robust and widely-used stablecoin, users now have access to stablecoin and crypto payment rails, alternative banking access, and global earnings opportunities.
“We want to bring emerging markets on-chain,” said James Zhang, Co-founder of Jambo. “Bringing Jambo to Solana and Tether allows us to provide a comprehensive solution that addresses the unique needs of these regions.”
“Emerging markets stand out as promising grounds for financial inclusion. Their demand for tools like USDT fuels our dedication to shaping a brighter financial future for users in these regions.” said Paolo Arodino, CEO, Tether. “By providing affordable access to web3 technologies through the JamboPhone and leveraging the power of the Solana blockchain, Jambo is empowering users in these regions with the tools they need to participate in the global digital economy. The integration of SPL USDT as a reward mechanism further strengthens this initiative, offering users a stable and secure digital asset.”
Learn more about the latest from Jambo on X and purchase your JamboPhone at JamboPhone.xyz. Join the Jambo Community and lead web3 adoption with us on Telegram.
- 0
- By Rabindra
17, Jul 2024
U.S. Precision Medicine, Inc. Signs MOU to Deploy microNeb’s VIGIL Series Inhaler Technology to Enhance Absorption of Its New Drug Candidate in IND Process
St. Petersburg, FL, July 17, 2024 — Frederick Fey, co-Founder and CEO of USPM, stated, “The use of a nebulizer/inhaler from microNeb for U.S. Precision Medicine’s new cancer drug candidate can offer several specific advantages for cancer patients compared to oral or IV administration:
1. Targeted Delivery to Lungs: For lung cancer or cancers that have spread to the lungs and respiratory system, an aerosolizer targets the medication directly to the affected tissues, potentially enhancing its effectiveness.
2. Elimination of IV access: Utilizing this method for chemotherapy substantially reduces the risk of infections and subsequent hospital readmissions associated with IV delivery, which is prone to complications such as catheter-related bloodstream infections. Studies show that CRBSIs occur in up to 25% of patients with central lines, leading to extended hospital stays, increased healthcare costs, and, in severe cases, mortality.
3. Significant Reduction in Infection Rates: Alternative methods for drug delivery have been clinically shown to greatly reduce infection rates and decrease infection- related hospital readmissions by 50%.
4. Enhanced Patient Quality of Life: Improve the quality of life for patients by lowering the rate of invasive procedures and lower anxiety associated with potential complications.
5. Optimized Healthcare Resource Use: Improves patient outcomes and promotes more efficient use of healthcare resources.
6. Minimized Systemic Side Effects: By targeting delivery to the lungs, the drug’s systemic exposure is minimized, which in turn reduces the side effects often associated with oral or IV treatments.
7. Rapid Onset of Action: Inhalation leads to quicker absorption through the lungs into the bloodstream, providing a faster therapeutic effect compared to oral medications.
8. Precision Dosing: The design feature of the VIGIL delivers exact doses, crucial for maintaining optimal therapeutic levels while avoiding toxicity.
9. Circumvention of First-Pass Metabolism: Unlike oral drugs, inhaled medications avoid initial processing by the liver, achieving more consistent dosing due to bioavailability.
10. Customizable Treatments: Nebulized treatment can be tailored to individual patient needs, allowing for personalized dosage and formulation adjustments to optimize therapeutic outcomes.
These advantages highlight the potential of microNeb’s technology to improve the administration and effectiveness of USPM’s new cancer drug candidate, offering substantial benefits to patients battling cancer.
Brian Artze, CEO of microNeb, added, “With our sophisticated inhalation technology and formulation expertise, we are transforming the delivery of pharmaceuticals and wellness products. Our dedication to quality and innovation compels us to develop cutting-edge solutions with a team committed to improving patient outcomes. Our Personal Nebulizing Devices (PNDs) represent the future of precise medication delivery, boosting efficacy in numerous medical applications. We are excited to support U.S. Precision Medicine’s mission to introduce their new, promising cancer drug candidate and look forward to progressing through the trials together.”
U.S. Precision Medicine, Inc. and microNeb, Inc. extend their heartfelt gratitude to everyone involved in making this collaboration happen. A special thanks to Scott Kelly and Black Dog Venture Partners for their invaluable contributions to this achievement. Your support and partnership have been instrumental in our progress and success.
17, Jul 2024
Nuvem, a Leading Pharmacy Technology and Services Company Appoints New CTO
Mount Laurel, NJ, July 17, 2024— Nuvem, a high-growth, healthcare technology company offering an integrated suite of pharmacy claims administration technology, high-level of 340B support and services and onsite pharmacy management services to safety net healthcare providers, announced that Jim Harter has joined the Company as its new Chief Technology Officer.
Mr. Harter brings a wealth of expertise and leadership to his role at Nuvem, as Chief Technology Officer (CTO), Jim is responsible for the management of all aspects of software engineering, data engineering, and DevOps. He has a proven track record as a CTO and in technology with extensive experience in software architecture, data analytics, and cloud computing. Most recently, he served as the CTO of Groups Recover Together, an Opioid Use Disorder (OUD) treatment provider. While there he helped develop, build and launch a telemedicine platform that supports their unique care model and improve access for patients. Prior to that, Jim served as the Chief Architect and Chief Technology Officer of TractManager, a provider of several healthcare-focused solutions such as contract lifecycle management, purchasing analysis, value analysis, and provider credentialing until its acquisition by symplr. In addition, Jim was also the CTO of RemitDATA, a healthcare software company with solutions for revenue cycle management (RCM) analytics and denial management, until its acquisition by eSolutions. Jim is a former nuclear submarine officer in the U.S. Navy and holds a B.S. in Chemistry from the U.S. Naval Academy and an M.S. in Chemistry from the University of Maryland.
“I am honored and thrilled to be joining the remarkable team at Nuvem, especially at such an exciting time,” said Jim Harter, Nuvem’s new CTO. “I am excited to further shape our technology strategy and to accelerate our pace of innovation for our clients and partners across the country. With a robust technological foundation Nuvem is positioned to continue to contribute to the ongoing pharmacy technological transformation in this market.”
“We are thrilled to have Jim on board as our new CTO,” said Matt Umscheid, CEO of Nuvem. “His extensive experience and proven leadership skills make him an invaluable asset to our team. We are confident that Jim will help us continue to deliver cutting-edge solutions for clients, pharmacies and patients while maintaining the highest standards.”
17, Jul 2024
ShatterGARD’s New Website Simplifies Ordering of Security Window Film
Atlanta, GA, July 17, 2024 — ShatterGARD, Inc., the industry leader in security window film, is proud to announce the launch of its newly designed website, featuring the first-of-its-kind turnkey online ordering system. This industry-first innovation allows consumers to seamlessly obtain a quote for ShatterGUARD glass protection film by simply providing the window dimensions and quantities. ShatterGARD customers can easily schedule a convenient installation appointment online through the website, eliminating the need for phone calls or in-person consultations. Additionally, customers can reschedule installation dates if necessary. Contracts and warranties are also managed through the streamlined online portal.
This groundbreaking system is a testament to ShatterGARD’s commitment to enhancing the customer experience by integrating advanced technologies into the ordering process. The state-of-the-art system ensures that consumers can enjoy the convenience of a fully digital interaction, from initial inquiry to final installation.
“We are thrilled to introduce our new website, which revolutionizes the way our customers interact with our company,” said Jordan Frankel, founder and CEO of ShatterGARD. “Our goal has always been to provide exceptional products with unparalleled convenience. Our online ordering system sets a new standard in the security industry, making it easier than ever for homeowners, businesses, and government entities to protect their property and people with ShatterGUARD’s state-of-the-art glass protection coatings.”
ShatterGARD’s optically clear security and safety films are renowned for their ability to safeguard people against break-ins, severe weather, and even explosions. Manufactured in the United States, ShatterGUARD glass coatings offer a robust layer of protection that holds shattered glass in place, significantly reducing the risk of injury and property damage. Trusted by homeowners, businesses, school systems, the United States military, and even former US presidents, ShatterGARD products are recognized worldwide for their superior effectiveness, durability, and lifetime warranty.
The launch of this one-of-a-kind and convenient online ordering system aligns with ShatterGUARD’s ongoing mission to provide top-tier security and safety film solutions. The ShatterGARD company is in the process of filing a patent for the custom coding behind this innovative system, further solidifying its position as a trailblazer in the industry.
To celebrate the launch, the first 100 customers to complete a ShatterGARD installation through the website’s new online ordering system will receive a free OnGARD door brace ($149 value). Praised by locksmiths, security professionals, and law enforcement, the OnGARD security door brace withstands up to 3,100 pounds of violent force, resisting door kick-ins, sledgehammers, and battering rams.
17, Jul 2024
MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy
Newton, MA, July 17, 2024 — Courage, a pre-clinical stage biotech company, announced groundbreaking results, funded in part by an NIDDK funded STTR research grant on obesity. The article “Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice” was published in the Journal of Clinical Investigation by senior author and Courage co-founder Dr. Roger Cone. It reports on synergy between GLP1RA and MC4R agonist drugs, demonstrating that low doses of MC4R agonists can significantly improve the dose-responsiveness of GLP1RA drugs to reduce food intake and drive weight loss through a novel mechanism that can improve GLP1RA weight loss efficacy without increasing side effects.
“This synergy between the MC4R circuit and GLP1RA agents could revolutionize the obesity treatment landscape similar to how GLP1/GIP combinations such as tirzepatide have recently shown dramatic improvements in weight loss,” said Dan Housman CEO.
Courage completed a successful four-year drug discovery campaign resulting in a market leading portfolio of optimized MC4R peptide agonist drug candidates designed to address the combination opportunity. Clinical candidates have demonstrated significantly higher potency and selectivity in animal models than setmelanotide, the only MC4R agonist currently approved for obesity treatment. The selectivity eliminates MC1R activity which drives a pigmentation side effect that has limited pharma development of MC4R agonists in dietary obesity. Combining Courage products with GLP1RA drugs such as Ozempic and Mounjaro in new ways is expected to improve the safety of GLP1RA drugs by lowering nausea, increasing physical activity, and reducing gastrointestinal discomfort.
“Based on their deep expertise in the field of melanocortin biology, Courage scientists have developed a range of peptide drugs that activate the MC4R. The potency and specificity of these drugs represent a significant advance on the only currently licensed activator of this receptor, setmelanotide. Their current paper in the Journal of Clinical Investigation Dahir et al adds to the evidence that combining low doses of a melanocortin 4 agonist with anti-obesity drugs acting through the GLP1Receptor can lead to greater weight loss in mice than when these drugs are used alone. Combining a specific and potent MC4R agonist with a drug acting on GLP1R opens up the exciting possibility of novel “dual action” anti-obesity agents with improved efficacy, safety and tolerability said Stephen O’Rahilly, Professor of Clinical Biochemistry and Medicine at the University of Cambridge and chair of Courage’s Scientific Advisory Board.
The company is initiating pre-clinical studies to bring product candidates into the clinic. Additionally, Courage is seeking partnerships with GLP1RA drug companies.
Go to the article: “Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice,” Journal of Clinical Investigation.
17, Jul 2024
Paragon Theaters Launches Sensory Friendly Screenings for Kids of All Ages
Deerfield Beach, FL, July 17, 2024 –Paragon Theaters, home of the exclusive enclave of Lux Box VIP Dine-in Seats and Axis15 and Axis15 Extreme large format screens, is excited to announce the launch of their kids Sensory Friendly Screenings, starting with Universal Pictures smash hit Despicable Me 4, Saturday, July 20, at all Paragon locations nationwide.
Paragon Theaters wants to ensure that all children have the opportunity to see their favorite films on the big screen. That said, for those kids who may need a little extra assistance, Paragon will be screening the latest family films in an auditorium where the lights are fully on, the sound levels are kept low and to a minimum, and it’s actually okay for kids to get up and move around, talk, and even dance in the aisles. Paragon plans on holding these screenings monthly on a Saturday at 10:00am, and all tickets for children and adults are only $5.
The following are the current list of titles that Paragon intends to screen as Sensory Friendly for the remainder of the year (please note that all dates and films are subject to change):
Despicable Me 4 – July 20, 2024
Harold and the Purple Crayon – August 8, 2024
Transformers One – September 28, 2024
The Wild Robot – October 12, 2024
Moana Two – December 14, 2024
“Paragon Theaters is excited to launch special needs sensory friendly screenings, an initiative that embodies our dedication to the communities we live and work in,” said Mike Whalen and Mike Wilson, owners of Paragon Theaters. “These screenings hold a deep meaning for our team, as they reflect our commitment to providing inclusive and enjoyable experiences for all our guests. We are extremely proud of this program and look forward to its success for many years to come.”
17, Jul 2024
Crack the Code of Arduino Microcontroller Development and Embedded Engineering with Nurve Network’s Newest Udemy Course
Austin, TX, July 17, 2024 — Embedded engineering, “edge computing” and IOT are going to continue to grow into the foreseeable future and exceed $190B by 2032 (GMI Research). With advances in computation, miniaturization, low power design, wireless communications, and sensors, the need for “embedded engineers” and experts in microcontrollers, firmware, and embedded development is going to skyrocket. Additionally, with AI in the limelight, more and more applications will require AI enabled hardware. This means the need for students and engineers entering the job market or pivoting from other engineering fields to electronics can greatly benefit by mastering embedded engineering fundamentals.
Nurve Network’s Andre LaMothe is well known as a Master Instructor/Author in Electrical Engineering, Game Development and 2D/3D Computer Graphics (over 90,000 students on Udemy). He has launched a new course on Udemy, over 3 years in the making – “Crash Course Arduino and Microcontroller Development.” He has built the most complete course on embedded engineering, microcontrollers and the Arduino platform for beginners. The course takes you on a journey through countless topics such as:
– Learn about microcontrollers, microprocessors and their internal architecture including how instructions are executed, ALUs, Buses, MMUs, DMA and more.
– Learn the Arduino platform’s hardware, software and APIs as a working platform to bridge the gap to more complex systems like ARM later in the course.
– Understand C/C++ from the ground up and how to write effective firmware for embedded systems and memory/compute constrained systems.
– Learn how processors run at the bare metal level including inline and external assembly language programming and interfacing with C/C++.
– Conquer advanced Computer Science subjects such as optimization theory, data structures, recursion, interrupts, and Big O analysis.
– Explore multitasking on microcontrollers by developing an interrupt based-round-robin kernel as well as using FreeRTOS.
– Become expert in numerous tools such as compilers, IDEs, TinkerCAD, EasyEDA, Replit, VSCode, CodeLite, Fritzing, MPLabX, STM32CubeIDE, and more.
– Overcome programmable logic and the fundamentals of CPLDs, PALs, GALs, and FPGAs along with a primer on hardware description languages and CUPL.
– Conquer power management and sleep modes and how to shut peripherals down in your embedded designs, wake from interrupts, and manage power effectively.
– Master one of the fastest growing and highest paid engineering fields in the world.
“Crash Course Arduino and Microcontroller Development” features over 111 hours of video and 128 lectures and is currently rated at 5 stars.
17, Jul 2024
Introducing My Friend Toothy Brushing and Flossing Charts
Ottawa, Canada, July 17, 2024 — Stacey Laviolette, a driven mom from Ottawa, Canada, is thrilled to announce the release of her highly anticipated children’s book, My Friend Toothy® Brushing and Flossing Charts, now available on Amazon. This innovative and interactive book is designed to make dental care fun and educational for children, helping them develop lifelong healthy habits.
My Friend Toothy® Brushing and Flossing Charts is a 112-page activity book packed with engaging dental activities, jokes, fun facts, and more. The book features a 26-week program with morning and night charts, encouraging kids to track their brushing and flossing routines from Monday to Sunday. The colorful illustrations and interactive content make it an enjoyable experience for both children and their parents.
“Promoting good dental habits from an early age is crucial, and I wanted to create a resource that makes this important routine fun and exciting for kids,” said Stacey Laviolette. “With this book, children can learn about dental health in an engaging way, making brushing and flossing something they look forward to every day.”
Stacey Laviolette is a dedicated mom who is passionate about helping parents and guardians address the growing problem of children’s dental health. After struggling to address her own daughter’s multiple cavities and hearing countless stories from parents facing similar challenges, Stacey created the My Friend Toothy® series and plushy to make learning about brushing and flossing fun and interactive. Having sold thousands of books and receiving rave reviews from satisfied customers, Stacey is eager to explore opportunities to partner with organizations to bring her series to more children and families.
Stacey’s mission is to encourage children to develop healthy hygiene habits at home to prevent cavities from forming. She strives to educate families to use proper dental hygiene techniques so they can be healthy, proud, and confident for every dental visit.
“My dream is to get onto Dragons’ Den (the Canadian version of Shark Tank) to promote my brand, My Friend Toothy®, and help families all over the world make brushing and flossing fun,” added Stacey.
With dental health being a significant aspect of children’s overall well-being, My Friend Toothy® aligns with ongoing discussions about preventative healthcare. It is a resource that dental professionals and educators can recommend to parents as a fun and effective tool for improving their children’s dental health.
17, Jul 2024
Active Care Files Patent for Revolutionary Senior Healthcare Integration Platform
Tyler, TX, July 17, 2024 — Active Care, a pioneering force in senior care technology, is proud to announce the filing of a patent for its groundbreaking platform. Developed by Active Therapy Management LLC, the Active Care platform represents a significant leap forward in the integration and management of patient data for senior care facilities, offering a comprehensive solution to enhance patient outcomes and streamline care processes.
Patent-Pending Technology to Revolutionize Senior Care
The patent filing marks a major milestone for Active Care, underscoring its commitment to innovation in senior healthcare. The patent-pending technology of the Active Care platform integrates multiple Electronic Medical Record (EMR) systems into a single, cohesive interface, providing a comprehensive view of patient data. It is specifically designed to meet the unique needs of seniors in rehabilitation and nursing facilities, ensuring that healthcare providers have seamless access to critical information.
Addressing a Critical Need
The Active Care platform addresses the urgent need for a unified system that consolidates patient data from multiple EMR systems, making it easily accessible and manageable. This integration is crucial for improving the quality of care and operational efficiency in senior care facilities.
Empowering Families with critical health Information
The platform is primarily used by patients’ families, care teams, and MDS coordinators/billers in skilled nursing home facilities. It focuses on providing families with access to their loved ones’ health information, ensuring they are always informed and involved in the care process.
User-Friendly and Interactive
For patients’ families, the Active Care platform offers a user-friendly application that allows them to monitor the health status and progress of their loved ones. Families can access a personalized health dashboard that displays vital signs, medication schedules, therapy progress, and nutritional information. The application also enables families to set reminders, track health goals, and communicate with the care team, ensuring they are actively engaged in the care process.
Seamless Integration and Updates
The Active Care platform integrates data from various EMR systems used in Hospitals and Senir care facilities (Epic, Net Health, MatrixCare, PointClickCare are few of the well known EMRs in hospitals and senior care) into a central processing platform. This central platform analyzes, organizes, and updates the data, ensuring accuracy and currency. The platform features a dynamic dashboard tailored to different user roles, providing relevant and actionable information for each type of user. Built-in tools facilitate seamless communication and coordination among healthcare providers, patients, and their families, enhancing the overall care experience.
Visionary Leadership
Co-founded by Dr. Richa Kohli, PT, DPT, a visionary in the field of digital health, Active Care combines cutting-edge technology with a deep understanding of senior care needs. Dr. Kohli’s expertise and leadership have been instrumental in developing this platform, which aims to address the inefficiencies and challenges faced by healthcare providers in senior care settings.
Platform Capabilities
Active Care offers a range of features designed to improve the quality of care and operational efficiency in senior care facilities:
– Data Integration: The platform consolidates data from various EMR systems, allowing for updates and comprehensive patient records.
– User-Centric Design: Tailored interfaces for different user roles, including patients, families, care teams, and MDS coordinators/billers, ensure that relevant and actionable information is always at hand.
– Enhanced Communication: Built-in tools facilitate seamless communication between healthcare providers, patients, and their families, promoting better coordination and care.
– Billing Optimization: Tools designed for MDS coordinators/billers streamline the billing and documentation processes, ensuring accurate and timely reimbursements.
A Milestone in Senior Care
“We are thrilled to file this patent for the Active Care platform,” said Dr. Richa Kohli, PT, DPT, Co-founder of Active Therapy Management LLC. “Our platform is not just about integrating data; it’s about improving lives by providing healthcare providers with the tools they need to deliver exceptional care. The patent filing is a testament to our commitment to innovation and excellence in senior healthcare.”
17, Jul 2024
Image Options Announces Key Promotions to Enhance Management Structure and Drive Strategic Growth
Irvine, CA, July 17, 2024 –Image Options, a leader in experiential graphic and fabrication solutions, is proud to announce key promotions within its management team as part of its ongoing commitment to excellence and strategic growth. Effective July 17, Catina Talamantes will assume the role of Vice President of Operations, and Marisa Sedlak will be promoted to Director of Client Services.
Ms. Talamantes has been an invaluable member of the Image Options family since 2002. Her extensive understanding of all aspects of the business and her strong leadership qualities have significantly contributed to the company’s success. In her new role as Vice President of Operations, Catina will oversee the operational aspects of the business, ensuring efficiency and excellence in service delivery.
Marisa Sedlak, who joined Image Options in 2007, has consistently demonstrated exceptional dedication and talent. As the new Director of Client Services, Marisa will be responsible for overseeing client relations and ensuring that the company’s high standards of customer service are maintained.
Barry Polan, CEO of Image Options, expressed his enthusiasm for the promotions, stating, “I couldn’t be happier to call on two such talented and dedicated individuals to take on these critical roles in our business. These appointments will allow us to achieve our aggressive growth plans while always exceeding client expectations.”
These key initiatives include space optimization and further automation in its 125,000 sq/ft Orange County headquarters and Bay Area facility as well as the planned expansion into the Las Vegas market.
Please join them in congratulating Catina and Marisa on their well-deserved and exciting new roles. They look forward to their continued contributions to the success of Image Options.
